 He also thought that Crichton's "uncanny prescience in choosing subjects where fact will soon catch up with his fiction" was on target again, as the early hype over biotechnology has subsided and recent advances offer credible benefits.In "The Sunday Times" Joby Williams called the book "more a satiric polemic than the thriller we have come to expect from Crichton", and notes that there is no central character and the story is told as a collection of distinct episodes.Ridley described the plot as "a collection of short horror stories from the biotechnology industry," and "The Independent"′s view was similar.